| Long-term outcomes in elderly patients with ANCA-associated vasculitis D McGovern, SP Williams, K Parsons, TE Farrah, PJ Gallacher, ... Rheumatology 59 (5), 1076-1083, 2020 | 42 | 2020 |
| Avacopan for ANCA-associated vasculitis–information for prescribers D McGovern, RB Jones, LC Willcocks, RM Smith, DRW Jayne, ... Nephrology Dialysis Transplantation 38 (5), 1067-1070, 2023 | 5 | 2023 |
| The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials S Bate, D McGovern, F Costigliolo, PG Tan, V Kratky, J Scott, G Chapman, ... Journal of the American Society of Nephrology, 10.1681, 2024 | 4 | 2024 |
| # 4803 ANCA renal risk score 2023: the updated and revised ARRS S Bate, D Mcgovern, F Costigliolo, M Mysliveček, J Scott, G Chapman, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_4803, 2023 | 3 | 2023 |
| Outcomes in ANCA-associated vasculitis in Scotland: validation of the renal risk score in a complete national cohort DP McGovern, JS Lees, JP Traynor, B Mackinnon, S Bell, RW Hunter, ... Kidney International Reports 8 (8), 1648-1656, 2023 | 1 | 2023 |
| Lupus nephropathy and vasculitis D McGovern, L Willcocks, R Jones Medicine 51 (4), 280-287, 2023 | | 2023 |
| FC 065 PREDICTING OUTCOMES IN ANCA ASSOCIATED VASCULITIS: THE COMPLETE SCOTTISH EXPERIENCE D McGovern, J Lees, D Kidder, J Smith, J Traynor, N Dhaun, R Hunter, ... Nephrology Dialysis Transplantation 36 (Supplement_1), gfab136. 004, 2021 | | 2021 |
